期刊文献+

Valuable clinical indicators for identifying infantile-onset inflammatory bowel disease patients with monogenic diseases 被引量:3

下载PDF
导出
摘要 BACKGROUND Infantile-onset inflammatory bowel disease(IO-IBD)occurs in very young children and causes severe clinical manifestations,which has poor responses to traditional inflammatory bowel disease(IBD)treatments.At present,there are no simple and reliable laboratory indicators for early screening IO-IBD patients,especially those in whom the disease is caused by monogenic diseases.AIM To search for valuable indicators for early identifying IO-IBD patients,especially those in whom the disease is caused by monogenic diseases.METHODS A retrospective analysis was performed in 73 patients with IO-IBD admitted to our hospital in the past 5 years.Based on the next-generation sequencing results,they were divided into a monogenic IBD group(M-IBD)and a non-monogenic IBD group(NM-IBD).Forty age-matched patients with allergic proctocolitis(AP)were included in a control group.The clinical manifestations and the inflammatory factors in peripheral blood were evaluated.Logistic regression analysis and receiver operating characteristic(ROC)curve analysis were used to identify the screening factors and cut-off values of IO-IBD as well as monogenic IO-IBD,respectively.RESULTS Among the 44 M-IBD patients,35 carried IL-10RA mutations,and the most common mutations were c.301C>T(p.R101W,30/70)and the c.537G>A(p.T179T,17/70).Patients with higher serum tumor necrosis factor(TNF)-αvalue were more likely to have IBD[odds ratio(OR)=1.25,95%confidence interval(CI):1.05-1.50,P=0.013],while higher serum albumin level was associated with lower risk of IBD(OR=0.86,95%CI:0.74-1.00,P=0.048).The cut-off values of TNF-αand albumin were 17.40 pg/mL(sensitivity:0.78;specificity:0.88)and 36.50 g/L(sensitivity:0.80;specificity:0.90),respectively.The increased ferritin level was indicative of a genetic mutation in IO-IBD patients.Its cut-off value was 28.20 ng/mL(sensitivity:0.93;specificity:0.92).When interleukin(IL)-10 level was higher than 33.05 pg/mL(sensitivity:1.00;specificity:0.84),or the onset age was earlier than 0.21 mo(sensitivity:0.82;specificity:0.94),the presence of diseasecausing mutations in IL-10RA in IO-IBD patients was strongly suggested.CONCLUSION Serum TNF-αand albumin level could differentiate IO-IBD patients from allergic proctocolitis patients,and serum ferritin and IL-10 levels are useful indicators for early diagnosing monogenic IO-IBD.
出处 《World Journal of Gastroenterology》 SCIE CAS 2021年第1期92-106,共15页 世界胃肠病学杂志(英文版)
基金 Supported by Scientific Research Fund of Shanghai Municipal Health Commission,No.201640368 National Natural Science Foundation of China,No.81741103 The Shanghai Plan for Women and Children's Health Service Capacity Construction(Enhancing the Service Capacity of Shanghai Women and Children Health Care Institutions).
  • 相关文献

参考文献4

二级参考文献61

  • 1Martina Galatola,Erasmo Miele,Caterina Strisciuglio,Lorella Paparo,Daniela Rega,Paolo Delrio,Francesca Duraturo,Massimo Martinelli,Giovanni Battista Rossi,Annamaria Staiano,Paola Izzo,Marina De Rosa.Synergistic effect of interleukin-10-receptor variants in a case of early-onset ulcerative colitis[J].World Journal of Gastroenterology,2013,19(46):8659-8670. 被引量:7
  • 2江米足.青少年儿童炎症性肠病诊断指南(波尔图标准)[J].实用儿科临床杂志,2006,21(7):443-445. 被引量:22
  • 3De Bie CI, Buderus S, Sandhu BK, et al. Diagnostic workup of paediatric patients with inflammatory boweldisease in Europe: results of a 5-year audit of the EUROKIDS registry [ J ]. J Pediatr Gastroenterol Nutr, 2012, 54(3) :374-380.
  • 4Shim JO, Hwang S, Yang HR, et al. Intedeukin-10 receptor mutations in children with neonatalonset Crohn's disease and intractable tllcerating enterocolitis [ J ]. Eur J Gastroenterol Hepatol, 2013, 25(10) :1235-1240.
  • 5Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor[ J l. N Engl J Med, 2009, 361 (21) :2033-2045.
  • 6Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation [ J ]. J Allergy Clin Immuaol, 2013, 131 (3) :825-830.
  • 7Glocker EO, Kotlarz D, Klein C, et al. IL-10 and IL-lO receptor defects in humans [J].New York Academy of Sciences, 2011, 1246 : 102-107.
  • 8Finbloorn DS, Winestock KD. IL-10 induces tyrosinephosphorylation of tyk2 and JaM and the differential assembly of STAT1 and STAT3 complexes in human T cells and monocytes [J]. J Immunol, 1995, 155(3) :1079-1090.
  • 9O'Shea JJ, Murray PJ. Cytokine signaling modules in itdlammatory responses[J]. Immunity, 2008, 28(4):477-487.
  • 10Williams L, Bradley L, Smith A, et al. Signal transducer and activator of transcription 3 is the dominant mediator of the anti- inflammatory effects of IL-10 in human maerophages [ J ]. J Immunol, 2004, 172( 1 ) :567-576.

共引文献38

同被引文献26

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部